Articles published by PerkinElmer, Inc.
![](https://mms.businesswire.com/media/20220127005653/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Board Declares Quarterly Dividend
January 27, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20220111005093/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1, 2022
January 11, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20211221005052/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer to Present Virtually at J.P. Morgan Healthcare Conference
December 21, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20211208005595/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance
December 08, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20211129005745/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Confirms That Omicron Variant Does Not Impact SARS-CoV-2 Detection Capability of its RT-PCR Assays
November 29, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From PerkinElmer, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211116005087/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer to Present at Evercore ISI HealthCONx Conference 2021
November 16, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20211105005233/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer to Present at 2021 Stifel Healthcare Conference
November 05, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20211102006200/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Announces Financial Results for the Third Quarter of 2021
November 02, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
PerkinElmer Releases 2021 Corporate Social Responsibility Report
November 01, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20211027005996/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Board Declares Quarterly Dividend
October 27, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20211025005649/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20211012005899/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Schedules Earnings Call for Tuesday, November 2, 2021
October 12, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel
October 07, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20211005006175/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20210917005523/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend
September 17, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20210908006184/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Prices Offering of Senior Notes
September 08, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20210824005128/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20210819005021/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20210728005328/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20210726005241/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
PerkinElmer Board Declares Quarterly Dividend
July 23, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20210622005619/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20210607005615/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20210527005129/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
![](https://mms.businesswire.com/media/20210516005059/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC
May 17, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://mms.businesswire.com/media/20210512005955/en/1055400/5/1200px-PerkinElmer_logo.svg.jpg)
PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience
May 12, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
PerkinElmer to Host Virtual Investor and Analyst Day
May 04, 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers
PKI
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.